Parian Global Management LP Insulet Corp Transaction History

Parian Global Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $1.23 Million - $1.74 Million	-6,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$255.32 - $318.29 $8.09 Million - $10.1 Million	-31,700 Reduced 83.42%	6,300 $1.68 Million
Q4 2020 Feb 16, 2021	SELL	$215.97 - $265.89 $5.23 Million - $6.43 Million	-24,194 Reduced 38.9%	38,000 $9.71 Million
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $12 Million - $14.7 Million	62,194 New	62,194 $14.7 Million
Q2 2020 Aug 14, 2020	SELL	$159.17 - $224.73 $3.98 Million - $5.62 Million	-24,997 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $3.25 Million - $5.41 Million	24,997 New	24,997 $4.14 Million
Q1 2019 May 15, 2019	SELL	$72.44 - $101.87 $8.29 Million - $11.7 Million	-114,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.27 - $105.19 $8.39 Million - $12 Million	114,500 New	114,500 $9.08 Million

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Parian Global Management LP with notifications on news.